218 related articles for article (PubMed ID: 17467042)
1. A segment of Staphylococcus aureus clumping factor A with fibrinogen-binding activity (ClfA221-550) inhibits platelet-plug formation in mice.
Liu CZ; Huang TF; Tsai PJ; Tsai PJ; Chang LY; Chang MC
Thromb Res; 2007; 121(2):183-91. PubMed ID: 17467042
[TBL] [Abstract][Full Text] [Related]
2. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
Liu CZ; Shih MH; Tsai PJ
Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
[TBL] [Abstract][Full Text] [Related]
3. Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets.
Niemann S; Spehr N; Van Aken H; Morgenstern E; Peters G; Herrmann M; Kehrel BE
Circulation; 2004 Jul; 110(2):193-200. PubMed ID: 15197141
[TBL] [Abstract][Full Text] [Related]
4. A new feasible method for fibrinogen purification based on the affinity of Staphylococcus aureus clumping factor A to fibrinogen.
Liu CZ; Cheng HJ; Chang LY
Protein Expr Purif; 2008 Sep; 61(1):31-5. PubMed ID: 18558494
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro.
Kerrigan SW; Clarke N; Loughman A; Meade G; Foster TJ; Cox D
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):335-40. PubMed ID: 18063809
[TBL] [Abstract][Full Text] [Related]
6. Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B.
Miajlovic H; Loughman A; Brennan M; Cox D; Foster TJ
Infect Immun; 2007 Jul; 75(7):3335-43. PubMed ID: 17438032
[TBL] [Abstract][Full Text] [Related]
7. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A.
Loughman A; Fitzgerald JR; Brennan MP; Higgins J; Downer R; Cox D; Foster TJ
Mol Microbiol; 2005 Aug; 57(3):804-18. PubMed ID: 16045623
[TBL] [Abstract][Full Text] [Related]
8. Differential kinetics and molecular recognition mechanisms involved in early versus late growth phase Staphylococcus aureus cell binding to platelet layers under physiological shear conditions.
George NP; Konstantopoulos K; Ross JM
J Infect Dis; 2007 Aug; 196(4):639-46. PubMed ID: 17624852
[TBL] [Abstract][Full Text] [Related]
9. Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria.
Liu CZ; Huang HY; Tsai PJ; Shih MH
Thromb Res; 2005; 116(2):145-55. PubMed ID: 15907530
[TBL] [Abstract][Full Text] [Related]
10. Capsular polysaccharide masks clumping factor A-mediated adherence of Staphylococcus aureus to fibrinogen and platelets.
Risley AL; Loughman A; Cywes-Bentley C; Foster TJ; Lee JC
J Infect Dis; 2007 Sep; 196(6):919-27. PubMed ID: 17703424
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of piracetam on platelet-rich thrombus formation in an animal model.
Stockmans F; Deberdt W; Nyström A; Nyström E; Stassen JM; Vermylen J; Deckmyn H
Thromb Haemost; 1998 Jan; 79(1):222-7. PubMed ID: 9459351
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen.
McDevitt D; Nanavaty T; House-Pompeo K; Bell E; Turner N; McIntire L; Foster T; Höök M
Eur J Biochem; 1997 Jul; 247(1):416-24. PubMed ID: 9249055
[TBL] [Abstract][Full Text] [Related]
13. The glycoprotein VI-phospholipase Cgamma2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo.
Munnix IC; Strehl A; Kuijpers MJ; Auger JM; van der Meijden PE; van Zandvoort MA; oude Egbrink MG; Nieswandt B; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2673-8. PubMed ID: 16254207
[TBL] [Abstract][Full Text] [Related]
14. Blockade of glycoprotein IIb/IIIa mediates the antithrombotic activity of butanol fraction of Actinostemma lobatum Maxim.
Kim KH; Lee HJ; Lee JH; Jang YS; Kim DK; Shim BS; Cho KH; Ko SG; Ahn KS; Kim SH
J Ethnopharmacol; 2008 Mar; 116(3):431-8. PubMed ID: 18243609
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
[TBL] [Abstract][Full Text] [Related]
16. Salsolinol, an endogenous neurotoxin, enhances platelet aggregation and thrombus formation.
Bae ON; Kim YD; Lim KM; Noh JY; Chung SM; Kim K; Hong S; Shin S; Yoon JH; Chung JH
Thromb Haemost; 2008 Jul; 100(1):52-9. PubMed ID: 18612538
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effect of a protein-type I class snake venom metalloproteinase, kistomin, is mediated by affecting glycoprotein Ib-von Willebrand factor interaction.
Hsu CC; Wu WB; Chang YH; Kuo HL; Huang TF
Mol Pharmacol; 2007 Oct; 72(4):984-92. PubMed ID: 17609416
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the role of adjacent amino acids to the 313-320 sequence of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
Mitsios JV; Stamos G; Rodis FI; Tsironis LD; Stanica MR; Sakarellos C; Tsoukatos D; Tsikaris V; Tselepis AD
Platelets; 2006 Aug; 17(5):277-82. PubMed ID: 16928597
[TBL] [Abstract][Full Text] [Related]
20. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.
Stoll P; Bassler N; Hagemeyer CE; Eisenhardt SU; Chen YC; Schmidt R; Schwarz M; Ahrens I; Katagiri Y; Pannen B; Bode C; Peter K
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1206-12. PubMed ID: 17322097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
